miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]

Li F, Wang F, Zhu C, Wei Q, Zhang T, Zhou YL. Int J Nanomedicine. 2018;13:2295–2307. The authors have advised Figure 2B on page 2301 is incorrect. Due to an error at the time of figure assembly B1 and B2 were duplicated. The correct Figure 2 is shown bel...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Li F, Wang F, Zhu C, Wei Q, Zhang T, Zhou YL
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	hepatocellular carcinoma nanoparticle mir-221 biomarker therapeutic target Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/285b634ed73b48069d0fb1ac8ea69293
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:285b634ed73b48069d0fb1ac8ea69293
record_format	dspace
spelling	oai:doaj.org-article:285b634ed73b48069d0fb1ac8ea692932021-12-02T11:07:47ZmiR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]1178-2013https://doaj.org/article/285b634ed73b48069d0fb1ac8ea692932020-10-01T00:00:00Zhttps://www.dovepress.com/corrigendum-mir-221-suppression-through-nanoparticle-based-mirna-deliv-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Li F, Wang F, Zhu C, Wei Q, Zhang T, Zhou YL. Int J Nanomedicine. 2018;13:2295–2307. The authors have advised Figure 2B on page 2301 is incorrect. Due to an error at the time of figure assembly B1 and B2 were duplicated. The correct Figure 2 is shown below. The authors apologize for this error and advise it does not affect the results of the paper. Read the original articleLi FWang FZhu CWei QZhang TZhou YLDove Medical Pressarticlehepatocellular carcinomananoparticlemir-221biomarkertherapeutic targetMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 8293-8294 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	hepatocellular carcinoma nanoparticle mir-221 biomarker therapeutic target Medicine (General) R5-920
spellingShingle	hepatocellular carcinoma nanoparticle mir-221 biomarker therapeutic target Medicine (General) R5-920 Li F Wang F Zhu C Wei Q Zhang T Zhou YL miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
description	Li F, Wang F, Zhu C, Wei Q, Zhang T, Zhou YL. Int J Nanomedicine. 2018;13:2295–2307. The authors have advised Figure 2B on page 2301 is incorrect. Due to an error at the time of figure assembly B1 and B2 were duplicated. The correct Figure 2 is shown below. The authors apologize for this error and advise it does not affect the results of the paper. Read the original article
format	article
author	Li F Wang F Zhu C Wei Q Zhang T Zhou YL
author_facet	Li F Wang F Zhu C Wei Q Zhang T Zhou YL
author_sort	Li F
title	miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
title_short	miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
title_full	miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
title_fullStr	miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
title_full_unstemmed	miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
title_sort	mir-221 suppression through nanoparticle-based mirna delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker [corrigendum]
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/285b634ed73b48069d0fb1ac8ea69293
work_keys_str_mv	AT lif mir221suppressionthroughnanoparticlebasedmirnadeliverysystemforhepatocellularcarcinomatherapyanditsdiagnosisasapotentialbiomarkercorrigendum AT wangf mir221suppressionthroughnanoparticlebasedmirnadeliverysystemforhepatocellularcarcinomatherapyanditsdiagnosisasapotentialbiomarkercorrigendum AT zhuc mir221suppressionthroughnanoparticlebasedmirnadeliverysystemforhepatocellularcarcinomatherapyanditsdiagnosisasapotentialbiomarkercorrigendum AT weiq mir221suppressionthroughnanoparticlebasedmirnadeliverysystemforhepatocellularcarcinomatherapyanditsdiagnosisasapotentialbiomarkercorrigendum AT zhangt mir221suppressionthroughnanoparticlebasedmirnadeliverysystemforhepatocellularcarcinomatherapyanditsdiagnosisasapotentialbiomarkercorrigendum AT zhouyl mir221suppressionthroughnanoparticlebasedmirnadeliverysystemforhepatocellularcarcinomatherapyanditsdiagnosisasapotentialbiomarkercorrigendum
_version_	1718396218358366208

miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]

Ejemplares similares